Cambrian BioPharma Inc bought SNSE
December 9, 2025 · Form 4 insider transaction
Cambrian BioPharma Inc bought 395 shares of SNSE at $6.40 per share, a transaction worth $2.5K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
395
Price
$6.40
Total value
$2.5K
InsiderCambrian BioPharma Inc
Role10% owner
CompanySNSE
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateDecember 9, 2025
Filing dateDecember 10, 2025
Shares owned after155,983
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
These shares are held by Cambrian Biopharma, Inc., a Delaware corporation ("Cambrian"). The Chief Executive Officer of Cambrian, James Peyer, may direct the voting and disposition of the shares held by Cambrian, subject in certain instances to the approval of Cambrian's Board of Directors. Mr. Peyer disclaims beneficial ownership of such shares.